Trial intelligence / Profile preview

MEBO vs Hyaluronic Acid for Pain After Gingival Graft

NCT03728244Phase 2Unknown

Sponsor
Cairo University
Start
Feb 2019
Primary completion
Nov 2019
Modality
Hydrogel Systems
01

Overview

A Phase 2 trial of MEBO Moist Burn Ointment, hyaluronic acid sodium composite gel for injection in postoperative pain, sponsored by Cairo University. Status: unknown.

02

Drugs

MEBO Moist Burn Ointmenthyaluronic acid sodium composite gel for injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03728244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03728244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call